Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT 2025

Elevated Gradients Early After TAVR: HALT or PPM? Diagnosis and Management

Presenter: Amr E. Abbas

October 28, 2025

Presentation TCT 2025

TCT 228: Automatic detection and grading analysis of hypoattenuated leaflet thickening (HALT) after TAVR using artificial intelligence based imaging evaluation method

Presenter: Dejing Feng

October 25, 2025

Presentation NY Valves 2025

Thrombosis and HALT in TTVR: Knowns, Unknowns, and Clinical Implications

Presenter: Robin Le Ruz

June 26, 2025

Presentation NY Valves 2025

Management of HALT After TAVR: Anticoagulation, Which Agent, How Long

Presenter: George D. Dangas

June 26, 2025

News Conference News EuroPCR 2025

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Michael O'Riordan

May 29, 2025

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

News Opinion Off Script

Q&A: Wayne Batchelor Reflects on the State of Medical Research Early in the Second Trump Term

Wayne Batchelor, MD, MHS, MBA

February 07, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2025

Shelley Wood

January 31, 2025

News Daily News

Early Actions by Trump Administration Sow Uncertainty for CV Research

Todd Neale

January 30, 2025

News Daily News

J&J Halts Varipulse Pulsed-Field Ablation Cases in the US

Todd Neale

January 08, 2025

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

Advertisement

Elevated Gradients Early After TAVR: HALT or PPM? Diagnosis and Management

TCT 228: Automatic detection and grading analysis of hypoattenuated leaflet thickening (HALT) after TAVR using artificial intelligence based imaging evaluation method

Thrombosis and HALT in TTVR: Knowns, Unknowns, and Clinical Implications

Management of HALT After TAVR: Anticoagulation, Which Agent, How Long

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Q&A: Wayne Batchelor Reflects on the State of Medical Research Early in the Second Trump Term

TCTMD’s Top 10 Most Popular Stories for January 2025

Early Actions by Trump Administration Sow Uncertainty for CV Research

J&J Halts Varipulse Pulsed-Field Ablation Cases in the US

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content